A. Kuklinska

Hypotensive effect of atorvastatin is not related to changes in inflammation and oxidative stress

K. Kamiński, B. Mroczko, M. Szmitkowski, 2010, Pharmacological reports : PR.

Influence of atorvastatin on blood pressure control in treated hypertensive, normolipemic patients – An open, pilot study

K. Kamiński, B. Mroczko, M. Szmitkowski, 2010, Blood pressure.

High-sensitivity C-reactive protein and total antioxidant status in patients with essential arterial hypertension and dyslipidemia.

B. Mroczko, M. Szmitkowski, W. Musiał, 2009, Advances in medical sciences.

The benefits of repeated measurements of B-type natriuretic peptide in patients with first ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.

K. Kamiński, B. Sobkowicz, B. Mroczko, 2006, International heart journal.

Prognostic significance of the admission plasma B-type natriuretic peptide measurement in patients with first ST-elevation myocardial infarction in comparison with C-reactive protein and TIMI risk score.

B. Sobkowicz, B. Mroczko, M. Szmitkowski, 2007, Clinica chimica acta; international journal of clinical chemistry.

Apelin: a novel marker for the patients with first ST-elevation myocardial infarction

B. Sobkowicz, J. Małyszko, W. Musiał, 2010, Heart and Vessels.

Diagnostic Biomarkers of Essential Arterial Hypertension

B. Mroczko, M. Szmitkowski, M. Knapp, 2009 .

Diagnostic biomarkers of essential arterial hypertension: the value of prostacyclin, nitric oxide, oxidized-LDL, and peroxide measurements.

B. Mroczko, M. Szmitkowski, M. Knapp, 2009, International heart journal.

Low dose rofecoxib, inflammation and prostacyclin synthesis in acute coronary syndromes.

K. Kamiński, B. Sobkowicz, W. Musiał, 2005, Roczniki Akademii Medycznej w Bialymstoku.

Endothelial dysfunction and sympathetic nervous system activation in young patients with essential arterial hypertension and without hypercholesterolaemia

K. Kamiński, B. Mroczko, M. Szmitkowski, 2010, Acta cardiologica.